| 产品名称： | Saccharopolyspora erythraea (Waksman) Labeda |
|---|---|
| 商品货号： | TS207507 |
| Deposited As： | Streptomyces erythraeus (Waksman) Waksman and Henrici |
| Strain Designations： | M5-12259 Boots 903, CBS 727.72, ETH 14307, ETH 28344, ETH 28360, ETH 28391, HUT 6087, IAM 0045, IFO 13426, IMRU 3737, ISP 5517, MA-1625, NCIB 8594, NRRL 2338, RIA 1387 |
| Application： | Produces erythromycin Glycosylation of avermectin Hydroxylation of ivermectin aglycone |
| Isolation： | Soil, Philippines |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | no |
| Genome Sequenced Strain： | Saccharopolyspora erythraea NRRL2338 complete genome. |
| Type Strain： | yes |
| Comments： | Characterization Streptomyces halstedii Genome sequenced strain |
| Medium： | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26°C Atmosphere: Aerobic |
| Name of Depositor： | Eli Lilly & Co. |
| U.S. Patent Number： | |
| Chain of Custody： | ATCC <-- Eli Lilly & Co. |
| References： | Schulman M, et al. Microbial conversion of avermectins by Saccharopolyspora erythraea: hydroxylation at c-27. J. Antibiot. 47: 372-375, 1994. PubMed: 8175491 Bunch RL, McGuire JM. Erythromycin, its salts, and method of preparation. US Patent 2,653,899 dated Sep 29 1953 Arison BH, et al. Process for the glycostylation of avermectin compounds. US Patent 5,192,671 dated Mar 9 1993 Shirling EB, Gottlieb D. Cooperative description of type strains of Streptomyces. V. Additional descriptions. Int J Syst Bacteriol 22: 265-394, 1972. . . Bergeys Manual Syst. Bacteriol. 4: 2472, 1989. Labeda DP. Transfer of the type strain of Streptomyces erythraeus (Waksman 1923) Waksman and Henrici 1948 to the genus Saccharopolyspora Lacey and Goodfellow 1975 as Saccharopolyspora erythraea sp. nov., and designation of a neotype strain for Streptomyces erythraeus. Int. J. Syst. Bacteriol. 37: 19-22, 1987. Ettlinger L, et al. Zur Systematik der Actinomyceten. 4. Eine arteinteilung der Gattung Streptomyces Waksman et Henrici. Arch. Mikrobiol. 31: 326-358, 1958. Schulman M, et al. Microbial conversion of avermectins by Saccharopolyspora erythrea: hydroxylation at C28 published erratum appears in J. Antibiot. (Tokyo) 46: C-3, 1993. J. Antibiot. 46: 1016-1019, 1993. PubMed: 8344863 Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. |
| Cross References： | Nucleotide (GenBank) : AM420293 Saccharopolyspora erythraea NRRL2338 complete genome. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Saccharopolyspora erythraea (Waksman) Labeda |
|---|---|
| 商品货号： | TS207507 |
| Deposited As： | Streptomyces erythraeus (Waksman) Waksman and Henrici |
| Strain Designations： | M5-12259 Boots 903, CBS 727.72, ETH 14307, ETH 28344, ETH 28360, ETH 28391, HUT 6087, IAM 0045, IFO 13426, IMRU 3737, ISP 5517, MA-1625, NCIB 8594, NRRL 2338, RIA 1387 |
| Application： | Produces erythromycin Glycosylation of avermectin Hydroxylation of ivermectin aglycone |
| Isolation： | Soil, Philippines |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | no |
| Genome Sequenced Strain： | Saccharopolyspora erythraea NRRL2338 complete genome. |
| Type Strain： | yes |
| Comments： | Characterization Streptomyces halstedii Genome sequenced strain |
| Medium： | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26°C Atmosphere: Aerobic |
| Name of Depositor： | Eli Lilly & Co. |
| U.S. Patent Number： | |
| Chain of Custody： | ATCC <-- Eli Lilly & Co. |
| References： | Schulman M, et al. Microbial conversion of avermectins by Saccharopolyspora erythraea: hydroxylation at c-27. J. Antibiot. 47: 372-375, 1994. PubMed: 8175491 Bunch RL, McGuire JM. Erythromycin, its salts, and method of preparation. US Patent 2,653,899 dated Sep 29 1953 Arison BH, et al. Process for the glycostylation of avermectin compounds. US Patent 5,192,671 dated Mar 9 1993 Shirling EB, Gottlieb D. Cooperative description of type strains of Streptomyces. V. Additional descriptions. Int J Syst Bacteriol 22: 265-394, 1972. . . Bergeys Manual Syst. Bacteriol. 4: 2472, 1989. Labeda DP. Transfer of the type strain of Streptomyces erythraeus (Waksman 1923) Waksman and Henrici 1948 to the genus Saccharopolyspora Lacey and Goodfellow 1975 as Saccharopolyspora erythraea sp. nov., and designation of a neotype strain for Streptomyces erythraeus. Int. J. Syst. Bacteriol. 37: 19-22, 1987. Ettlinger L, et al. Zur Systematik der Actinomyceten. 4. Eine arteinteilung der Gattung Streptomyces Waksman et Henrici. Arch. Mikrobiol. 31: 326-358, 1958. Schulman M, et al. Microbial conversion of avermectins by Saccharopolyspora erythrea: hydroxylation at C28 published erratum appears in J. Antibiot. (Tokyo) 46: C-3, 1993. J. Antibiot. 46: 1016-1019, 1993. PubMed: 8344863 Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. |
| Cross References： | Nucleotide (GenBank) : AM420293 Saccharopolyspora erythraea NRRL2338 complete genome. |
